Brief: Elicera Receives Notice Of Allowance For European Patent
July 11 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* ELICERA THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR
EUROPEAN
PATENT PROTECTING THE ITANK TM PLATFORM
* ONCE GRANTED, PATENT CAN BE KEPT IN FORCE UNTIL 2036
Source text for Eikon: ID:nWkr5cmp2K
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application